Evidence map›Paper›PMID 9122176›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1997

Identification of a novel negative retinoic acid responsive element in the promoter of the human matrix Gla protein gene.

J Kirfel, M Kelter, L M Cancela, P A Price, R Schüle

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 51 citations in OpenAlex.

  1. Trial
  2. Article
  3. Keutel Syndrome, a Review of 50 Years of Literature.Frontiers in cell and developmental biology · 2021
    Review
  4. Article
  5. Small-molecule hormones: molecular mechanisms of action.International journal of endocrinology · 2013
    Article
  6. Article
  7. Article
  8. Article
  9. Intra- and interindividual variation in gene expression in human adipose tissue.Pflugers Archiv : European journal of physiology · 2007
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 3 countries.

J KirfelFakultät für Biologie der Universität Freiburg, Institut für Experimentelle Krebsforschung, Germany.
M Kelter
L M Cancela
P A Price
R Schüle
University of California, San Diego · USUniversity of Algarve · PT

Funding

REGULATION OF VITAMIN K-DEPENDENT BONE PROTEINSR01AR025921 · NIAMS · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI PRICE, PAUL A · 1986 to 2001
$469k
NIAMS NIH HHS AR25921
6 · The paper itself

Abstract

The vitamin K-dependent matrix Gla protein (MGP) is synthesized in a wide variety of tissues such as lung, heart, kidney, cartilage, and bone. Expression of the MGP gene is regulated by various growth factors, steroid hormones, and the vitamin A metabolite retinoic acid (RA). In this report, we present evidence that RA down-regulates MGP gene expression in different rat and human cell lines via endogenous retinoid receptors [RA receptor (RAR) and retinoid X receptor (RXR)]. Repression of the human MGP (hMGP) gene is specifically mediated by ligand-activated RAR and RXR. Deletion analysis led to the identification of a novel negative response element (NRE) within the hMGP promoter. DNA binding studies performed with bacterially expressed RAR/RXR reveal the formation of a specific heterodimer/NRE complex. Furthermore, electrophoretic mobility-shift assays performed with proteins from RA-treated cells show that endogenous RAR/RXR binds to the NRE. We demonstrate that the NRE contains a CCAAT box and that both RAR/RXR and CCAAT-binding proteins such as c/EBP beta recognize this common regulatory sequence in the hMGP promoter. Our results indicate that RA-mediated repression of the hMGP gene is due to binding of liganded RAR/RXR to a novel negative RA response element.

Indexed as

Extracellular Matrix ProteinsPromoter Regions, GeneticSequence DeletionAnimalsBase SequenceBinding SitesCalcium-Binding ProteinsCell LineDNADNA-Binding ProteinsGene Expression RegulationHumansMatrix Gla ProteinOligodeoxyribonucleotidesRatsReceptors, Retinoic AcidCalcium-Binding ProteinsDNADNA-Binding ProteinsExtracellular Matrix ProteinsMatrix Gla ProteinOligodeoxyribonucleotidesReceptors, Retinoic AcidRecombinant ProteinsRetinoid X ReceptorsTranscription FactorsTretinoinVitamin K

Identifiers

PMID9122176
PMCPMC20069
OpenAlexW2080703986

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.